EUVIMEDEUVIMED entdecken
Open Access

ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis

Junji Zhu iD, GuanQun Liu iD, Zuberwasim Sayyad, Christopher M Goins, Shaun R Stauffer, Michaela U Gack iD

Journal of Virology · 17.09.2024 · 98 (9)

DOI: 10.1128/jvi.00869-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 17.09.2024. Verfasst von Junji Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA. Hauptthemen laut MEDLINE: Ubiquitins, SARS-CoV-2, Ubiquitin-Protein Ligases, Coronavirus Papain-Like Proteases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon (IFN)-stimulated gene 15 (ISG15), a ubiquitin-like protein, is covalently conjugated to host immune proteins such as MDA5 and IRF3 in a process called ISGylation, thereby promoting type I IFN induction to limit the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, whether SARS-CoV-2 proteins can be directly targeted for ISGylation remains elusive. In this study, we identified the nucleocapsid (N) protein of SARS-CoV-2 as a major substrate of ISGylation catalyzed by the host E3 ligase HERC5; however, N ISGylation is readily removed through deISGylation by the papain-like protease (PLpro) activity of NSP3. Mass spectrometry analysis identified that the N protein undergoes ISGylation at four lysine residues (K266, K355, K387, and K388), and mutational analysis of these sites in the context of a SARS-CoV-2 replicon (N-4KR) abolished N ISGylation and alleviated ISGylation-mediated inhibition of viral RNA synthesis. Furthermore, our results indicated that HERC5 targets preferentially phosphorylated N protein for ISGylation to regulate its oligomeric assembly. These findings reveal a novel mechanism by which the host ISGylation machinery directly targets SARS-CoV-2 proteins to restrict viral replication and illuminate how an intricate interplay of host (HERC5) and viral (PLpro) enzymes coordinates viral protein ISGylation and thereby regulates virus replication. IMPORTANCE The role of protein ISGylation in regulating host cellular processes has been studied extensively; however, how ISG15 conjugation influences the activity of viral proteins, particularly coronaviral proteins, is largely unknown. Our study uncovered that the nucleocapsid (N) protein of SARS-CoV-2 is ISGylated by the HERC5 ISGylation machinery and that this modification impedes the functional assembly of N into oligomers ultimately inhibiting viral RNA synthesis. This antiviral restriction mechanism is antagonized by the PLpro deISGylation activity of SARS-CoV-2 NSP3. This study deepens our understanding of SARS-CoV-2 protein regulation by posttranslational modifications and may open new avenues for designing antiviral strategies for COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquitinsSARS-CoV-2Ubiquitin-Protein LigasesCoronavirus Papain-Like ProteasesRNA, ViralCytokinesCoronavirus Nucleocapsid ProteinsVirus ReplicationHumansHEK293 CellsPhosphoproteinsCOVID-19Protein MultimerizationProtein Processing, Post-TranslationalIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

HERC5ISG15ISGylationN proteinSARS-CoV-2papain-like protease

Substanzen

HERC5 protein, humanUbiquitinsISG15 protein, humanUbiquitin-Protein LigasesCoronavirus Papain-Like ProteasesRNA, ViralCytokinesnucleocapsid phosphoprotein, SARS-CoV-2Coronavirus Nucleocapsid Proteinspapain-like protease, SARS-CoV-2

Autor:innen und Institutionen

  • Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.
  • Department of Microbiology & Immunology, McGill University, Montreal, Quebec, Canada.
  • Center for Therapeutics Discovery, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Junji Zhu, GuanQun Liu, Michaela U Gack

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Zhu, J., Liu, G., Sayyad, Z., Goins, C. M., Stauffer, S. R., & Gack, M. U. (2024). ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis. Journal of Virology, 98(9). https://doi.org/10.1128/jvi.00869-24

Vancouver

Zhu J, Liu G, Sayyad Z, Goins CM, Stauffer SR, Gack MU. ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis. Journal of Virology. 2024;98(9). doi:10.1128/jvi.00869-24

BibTeX
@article{Zhu2024,
  author = {Zhu, Junji and Liu, GuanQun and Sayyad, Zuberwasim and Goins, Christopher M and Stauffer, Shaun R and Gack, Michaela U},
  title = {ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {9},
  doi = {10.1128/jvi.00869-24}
}
Kostenlos starten →